<font><font face="trebuchet ms,sans-serif">See the list of OA journal business models at the Open Access Directory.</font></font><div><font><font face="trebuchet ms,sans-serif"><a href="http://oad.simmons.edu/oadwiki/OA_journal_business_models">http://oad.simmons.edu/oadwiki/OA_journal_business_models</a></font></font></div>
<div><font><font face="trebuchet ms,sans-serif"><br></font></font></div><div><span style="font-family:'trebuchet ms',sans-serif"> Peter </span></div><div><span style="font-family:'trebuchet ms',sans-serif"><br>
</span></div><div><font face="trebuchet ms, sans-serif">Peter Suber</font></div><div><font face="trebuchet ms, sans-serif"><a href="http://gplus.to/petersuber">gplus.to/petersuber</a> </font></div><div><font><font face="trebuchet ms,sans-serif"><br>
</font></font><br><div class="gmail_quote">On Thu, Jul 19, 2012 at 8:17 AM, Peter Murray-Rust <span dir="ltr"><<a href="mailto:pm286@cam.ac.uk" target="_blank">pm286@cam.ac.uk</a>></span> wrote:<br><blockquote class="gmail_quote" style="margin:0 0 0 .8ex;border-left:1px #ccc solid;padding-left:1ex">
I am forwarding a message from the OKFN's open-access list (<a href="http://lists.okfn.org/mailman/listinfo/open-access" target="_blank">http://lists.okfn.org/mailman/listinfo/open-access</a> which uses the term strictly to mean BOAI-compliant).<br>
<br>The poster Katie runs a successful OA journal and asks how she can scale up without APCs. She raises the idea of a SCOAP3-like model for cancer. There must be a number of other people with the same question:<br>* they don't want closed access<br>
* they don't want author-side fees<br>* they recognize the money has to come from somewhere.<br><br>Katie (and I) would be interested to know of possible models and possible nuclei of like-minded groups.<br><br>This seems to me one of the key problems of the current time of transition.<br>
<br><div class="gmail_quote">---------- Forwarded message ----------<br>From: <b class="gmail_sendername">Katie Foxall</b> <span dir="ltr"><<a href="mailto:katie@ecancer.org" target="_blank">katie@ecancer.org</a>></span><br>
Date: Thu, Jul 19, 2012 at 10:53 AM<br>
Subject: Re: [Open-access] SCOAP3<br>To: <a href="mailto:open-access@lists.okfn.org" target="_blank">open-access@lists.okfn.org</a><br><br><br>Hello all<br>
<br>
I haven't posted [on OKFN open-access] before but have been following the discussions with much<br>
interest and have founds the info and links provided by various people<br>
really useful. I run an open access cancer journal <a href="http://ecancer.org/ecms" target="_blank">http://ecancer.org/ecms</a><br>
which has no author fees - we are currently mainly supported by charity<br>
funding but the journal has been growing at a great rate this year so I'm<br>
looking into accessing any funding that might be out there to support open<br>
access publishing. The reality is that we will have to start charging<br>
author fees at some point if we can't get more funding and we really don't<br>
want to do that as providing a free service for the oncology community is<br>
very important to us.<br>
<br>
So does anyone know whether there is anything like SCOAP3 in the field of<br>
medical publishing?<br>
<br>
Thanks in advance for any help or advice anyone might be able to give me,<br>
<br>
Katie Foxall<br>
<div><div><br>
-----Original Message-----<br>
From: <a href="mailto:open-access-bounces@lists.okfn.org" target="_blank">open-access-bounces@lists.okfn.org</a><br>
[mailto:<a href="mailto:open-access-bounces@lists.okfn.org" target="_blank">open-access-bounces@lists.okfn.org</a>] On Behalf Of<br>
<a href="mailto:cn@cameronneylon.net" target="_blank">cn@cameronneylon.net</a><br>
Sent: 18 July 2012 15:50<br>
To: <a href="mailto:open-access@lists.okfn.org" target="_blank">open-access@lists.okfn.org</a><br>
Subject: [Open-access] SCOAP3<br>
<br>
Not got so much press as the big announcements this week but this is a big<br>
deal. Communities can just decide unilaterally to move to OA.<br>
<br>
<a href="http://scoap3.org/news/news94.html" target="_blank">http://scoap3.org/news/news94.html</a><br>
_______________________________________________<br>
open-access mailing list<br>
<a href="mailto:open-access@lists.okfn.org" target="_blank">open-access@lists.okfn.org</a><br>
<a href="http://lists.okfn.org/mailman/listinfo/open-access" target="_blank">http://lists.okfn.org/mailman/listinfo/open-access</a><br>
<br>
<br>
_______________________________________________<br>
open-access mailing list<br>
<a href="mailto:open-access@lists.okfn.org" target="_blank">open-access@lists.okfn.org</a><br>
<a href="http://lists.okfn.org/mailman/listinfo/open-access" target="_blank">http://lists.okfn.org/mailman/listinfo/open-access</a><span class="HOEnZb"><font color="#888888"><br>
</font></span></div></div></div><span class="HOEnZb"><font color="#888888"><br><br clear="all"><br>-- <br>Peter Murray-Rust<br>Reader in Molecular Informatics<br>Unilever Centre, Dep. Of Chemistry<br>University of Cambridge<br>
CB2 1EW, UK<br><a href="tel:%2B44-1223-763069" value="+441223763069" target="_blank">+44-1223-763069</a><br>
</font></span><br>_______________________________________________<br>
GOAL mailing list<br>
<a href="mailto:GOAL@eprints.org">GOAL@eprints.org</a><br>
<a href="http://mailman.ecs.soton.ac.uk/mailman/listinfo/goal" target="_blank">http://mailman.ecs.soton.ac.uk/mailman/listinfo/goal</a><br>
<br></blockquote></div><br></div>